No Picture
News

Biocept Announces Clinical Validation and Commercial Launch of its Target Selector(TM) Multi-Gene Liquid Biopsy Panel for Lung Cancer

Biocept now positioned as the only commercial liquid biopsy provider that offers single-biomarker testing, tumor-specific panels, and circulating tumor cell analysis

SAN DIEGO, May 20, 2019 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC), a leading comm… […]

No Picture
News

Reneo Pharmaceuticals Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases

SAN DIEGO, May 20, 2019 /PRNewswire/ — Reneo Pharmaceuticals, a clinical stage pharmaceutical company, today announced that it has completed a $50 million Series A financing to develop therapies for diseases associated with deficits in cellular met… […]

No Picture
News

Respivant Sciences Announces Dosing of First Patient in Phase 2b Trial of RVT-1601 for the Treatment of Persistent Cough Due to Idiopathic Pulmonary Fibrosis

RVT-1601 previously demonstrated a statistically significant and clinically meaningful reduction in IPF-related cough in a Phase 2a studyRespivant also launches new website – IPFCough.com – as educational resource for patients and to increase awareness… […]

No Picture
News

Joint Educational Partnership to Train Physicians in Use of Endoscopic Ultrasound Will Launch at Digestive Disease Week

Educational program addresses training gap for practicing endoscopists in minimally invasive EUS procedures to diagnose and stage digestive disorders and diseases

CENTER VALLEY, Pa. and DOWNERS GROVE, Ill., May 16, 2019 /PRNewswire/ — Olympus Corpor… […]

No Picture
News

Wellspring Biosciences Announces Clearance of IND Application to Initiate Phase 1 Trial of KRAS G12C Mutant Inhibitor ARS-3248

SAN DIEGO, May 16, 2019 /PRNewswire/ — Wellspring Biosciences, Inc., a wholly owned subsidiary of Araxes Pharma, LLC, announced today that the U.S. Food and Drug Administration has cleared an investigational new drug (IND) application for ARS-3248,… […]

No Picture
News

Epic Sciences to Present New Data Identifying Multiple Cancer Biomarkers Associated with Treatment Response in Prostate and Bladder Cancer at ASCO 2019

SAN DIEGO, May 15, 2019 /PRNewswire/ — Epic Sciences, Inc. today announced its poster presentations for the upcoming 2019 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 31 through June 4 in Chicago, Illinois. The data … […]